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Campylobacter spp. particularly C. jejuni has been recognized as one of the most 
prevalent causes of foodborne bacterial illnesses in humans. Most previous studies have focused 
on the transmission routes of C. jejuni from commercial flock farms to the final retail product. 
To date, no in vivo studies have addressed the efficacy of sulfadimethoxine in the control of      
C. jejuni in poultry. This dissertation research proceeds along two lines of investigation. The 
objectives of the first line of investigation are to determine the enumeration of Campylobacter 
spp. and the prevalence on both Campylobacter spp. and C. jejuni on live egg shells, to detect the 
presence and extent of Campylobacter spp. and C. jejuni in live birds raised in battery-cage and 
cage-free systems and to determine to what extent these bacteria are present in drinking water, 
feed, enclosures and troughs. The objectives of the second line of investigation are to determine 
the effects of sulfadimethoxine antibiotic on the enumeration of Campylobacter spp. and the 
prevalence on both Campylobacter spp. and C. jejuni in broilers and to examine the effects of 
sulfadimethoxine antibiotic treatments on the enumeration of Campylobacter spp. and 
prevalence of Campylobacter spp. and C. jejuni from likely sources of cross-contamination to 
include drinking water, feed, enclosures and troughs. The results from the first line of 
investigation suggest that the vertical transmission of these bacteria from egg surfaces to newly 
hatched chicks is not a significant risk factor. Additionally, this study found that the horizontal 
transmission of Campylobacter spp. and C. jejuni among live broilers is significantly higher 
(P<0.05) raised in the cage-free system than in the battery-cage system. Prevalence of 
Campylobacter spp. and C. jejuni in the potential abiotic sources of cross contamination 
(drinking water, feed, enclosures and troughs) in the cage-free system was significantly higher 
than in the battery-cage system. The results from the second line of investigation also found that 
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drinking water may be a prime source of Campylobacter spp. and C. jejuni cross contamination. 
The use of antibiotic sulfadimethoxine can reduce the enumeration and prevalence of 















CHAPTER 1  
INTRODUCTION 
 
Campylobacte jejuni is an emerging food pathogen with a worldwide distribution. 
Infections caused by this organism are characterized by self-limiting watery and bloody diarrhea 
(Altekruse et al., 1999; Friedman et al., 2000; Skirrow and Blaser, 2000). The Center for Disease 
Control and Prevention (CDC) estimates that approximately 400 million cases of 
Campylobacter-associated gastroenteritis occur annually (Rao et al., 2001; Van et al., 2001) with 
an economic impact estimated in excess of $2 billion (Allos, 2011). 
Approximately 70% of human illnesses due to Campylobacter spp. are caused by the 
consumption or handling of raw or undercooked poultry (Friedman et al., 2000; Mead et al., 
1999). Additionally, Campylobacter spp. can be transmitted via contact with infected animals or 
their feces. Many animals carry Campylobacter spp. asymptomatically and shed the bacterium in 
their feces. Poultry, particularly broiler chickens, frequently harbor the bacterium.  
Currently, the ecology of Campylobacter spp. in the poultry reservoir is poorly 
understood, particularly with respect to the sources of infection and routes of transmission. It is 
thought that both vertical and horizontal transmission may affect the immune status of the 
poultry host (Ridley et al., 2011; Ellis-Iversen et al., 2012).  
Intervention strategies for Campylobacter infection in poultry should consider the 
complex nature of its transmission and may require the use of multiple approaches that target 
different segments of the poultry production system (Irene et al., 2010). Most studies have 
concentrated on the transmission routes from commercial farm flocks to carcasses after slaughter 
and to retail products (Dickins et al., 2002; Takahashi et al., 2006; Lienau et al., 2007; Praakle-
Amin et al., 2007; Ellerbroek et al., 2010).  
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Interest in animal welfare issues has spurred an increased interest in free range, small 
scale, and local poultry production. With these open air, less controlled environments an 
increased infection rate of Campylobacter might be an issue. Therefore, there is a need to control 
infection rates and identify potential cross contamination vectors associated with small-scale 
poultry production.   
According to the US Food and Drug Administration (2013), sulfadimethoxine is an 
antibiotic that had been administered in commercial poultry production to treat a variety of 
infections. These include respiration illnesses, coccidiosis, fowl cholera, and coryza (Wang et al., 
2012). Sulfadimethoxine inhibits the bacterial synthesis of folic acid (pteroylglutamic acid) from 
para-aminobenzoic acid (Vree and Hekster, 1987).  
To date, there have been no in vivo studies on the efficacy of sulfadimethoxine in the 
control of C. jejuni in broilers in small-scale poultry operations. Although largely unknown, the 
positive potential effects of sulfadimethoxine antibiotic treatment to control C. jejuni infection in 
chickens are explored.  
The present dissertation research is divided into two parts. In the first part, one objective 
is to determine the prevalence and enumeration of Campylobacter on the shells of eggs received 
from the hatchery during incubation. A second objective is to detect the presence and extent of 
Campylobacter in live birds over a six week period in the battery-cage and the cage-free systems. 
A third objective is to determine whether and to what extent Campylobacter is present in the 
drinking water, feed, enclosures and troughs of the experimental birds.  
In the second part of this dissertation research, one objective is to determine the effects of 
sulfadimethoxine antibiotic treatments on the enumeration of Campylobacter spp. and the 
prevalence on both Campylobacter spp. and C. jejuni in live birds over two separate six-week 
3 
 
periods. The second objective is to examine the effects of sulfadimethoxine antibiotic treatments 
on the enumeration of Campylobacter spp. and prevalence of Campylobacter spp. and C. jejuni 
from the likely sources of cross-contamination including drinking water, feed, enclosures and 
troughs.  
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CHAPTER 2  
LITERATURE REVIEW 
 
2.1 GENERAL CHARACTERISTICS   
Campylobacter was first recognized as the cause of infectious abortion in sheep during 
the early 1900s by McFadyean and Stockman (Butzler, 2004). Campylobacter species are 
classified in the family Campylobacteraceae (Vandamme, 2000). The generic name 
Campylobacter is derived from the Greek words campylos, which means curved and baktron, 
which means rod. The name Campylobacter or curved rod, therefore, describes the appearance 
of this organism under the microscope (Blaser and Cody, 1986). Campylobacter is a gram 
negative, slender, spiral-curved rod that causes intestinal infectious diseases worldwide (Keener 
et al., 2004).  
The members of the genus Campylobacter (C. jejuni, C. coli, C. lari, C. upsaliensis,       
C. helveticus, C. fetus, C. hyointestinalis, C. mucosalis, C. concisus, C. curvus, C. showae,        
C. rectus, C. sputorum, and C. gracilis) are associated with a wide variety of diseases in humans 
and animals although some are considered commensals (Hald et al., 2000). Within the genus, 
three species: C. jejuni, C. coli, and C. lari are known as thermophilic members of the genus and 
of clinical significance as they are the dominant causative agents of human campylobacteriosis 
(Dekeyser et al., 1972; Jacobs-Reitsma, 2000). C. jejuni has been recognized as an important 
cause of food-borne illness in humans since the late 1970s (Butzler, 2004; Skirrow, 1977).         
C. jejuni grows best in an atmosphere containing approximately 3-8% O2 and 5-15% CO2 
(Doyle, 1990; Nachamkin, 1999; Rowe and Madden, 2000). Although most Campylobacter spp. 
grow at 37°C, C. jejuni and C. coli show optimal growth at 42°C (Blaser, 2000; Doyle, 1990; 
Shane and Montrose, 1985).  
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2.2 CAMPYLOBACTER SPP. IN HUMANS  
Campylobacter spp. is one of the leading causes of bacterial gastroenteritis, causing an 
estimated 2.1-2.4 million cases in the U.S. annually (Samuel et al., 2004; Altekruse et al., 1999). 
These infections result in 13,000 hospitalizations, 100 deaths with costs exceeding over            
$1 billion annually. The infectious dose varies depending on both host and bacterial factors and 
ranges from 500-10
6
 organisms (Keener et al., 2004; Smith, 1995). Once ingested, the typical 
incubation period is 24-72 hours. Symptoms include severe acute diarrhea, with variable fever, 
myalgia, and headache. Infection is typically self-limiting in healthy individuals with resolution 
of symptoms within 1 week. However, in immunocompromised patients, infection often leads to 
bacteremia with significant mortality (Coker et al., 2002). 
Four species (C. jejuni, C. coli, C. lari and C. upsaliensis) are known as thermophilic 
Campylobacters and are clinically significant due to their dominant causative agents of human 
campylobacteriosis (Keener et al., 2004; Jacobs-Reitsma, 2000). C. jejuni is the predominant 
species that causes bacterial gastroenteritis in the U.S. and other developed countries, with        
C. coli placing second (Lastovica, 2006). In the U.S., campylobacteriosis and salmonellosis are 
the leading causes of bacterial foodborne illness. Transmission of Campylobacter spp. to humans 
generally occurs by either ingestion of contaminated food or water or by direct contact with fecal 
material from infected animals or persons.  
In humans, there are two types of illnesses associated with Campylobacter spp. 
infections. These are intestinal and extra-intestinal. Two types of diarrhea are usually observed 
with campylobacteriosis. One type is an inflammatory diarrhea, with slimy, bloody stools 
containing leukocytes.  The second type is non-inflammatory diarrhea, with watery stools and 
the absence of blood and leukocytes (Wassenaar, 1997). In some cases, intense abdominal pain, 
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headache, fever, cramping and vomiting can occur. Serious complications can arise such as 
Reiter‘s syndrome, Gullain-Barré syndrome, osteomyelitis, pancreatitis, nephritis, myocarditis, 
cystitis, septic abortion, and bacteremia (Keener et al., 2004; Winer, 2001; Altekruse et al., 
1999). Although campylobacteriosis does not usually lead to death, approximately 700 people in 
the U.S. succumb to this disease, often due to secondary complications (Saleha et al., 1998). A 
concern for those suffering from campylobacteriosis is that they might suffer from neurological 
sequelae months or even years afterwards. Two neuropathies associated with C. jejuni infections 
are Gullain-Barré syndrome (GBS) and Miller Fisher syndrome (MFS). Both of these syndromes 
are characterized by acute or sub–acute immune mediated neuropathies.  
Gullain-Barré syndrome is characterized by alexia, motor paralysis, an acellular increase 
in the total protein content in the cerebrospinal fluid and an inflammatory demyelinating 
polyradiculoneuropathy (Winer, 2001; Willison and O‘Hanlon, 2000). Gullain-Barré syndrome 
occurs in approximately 1 out of 100,000 people (Winer, 2001). The prevalence within infected 
people is estimated to be 1 out of 1,000 and can be even less depending on the strain 
(Nachamkin, 2002). Gullain-Barré syndrome cases are associated with nerve roots, causing 
mononuclear infiltration of peripheral nerves and this eventually leads to primary axonal 
degeneration or demyelination. Molecular mimicry is believed to be the cause of GBS because a 
few peripheral nerves of the human neurological system share similar molecules with antigens 
on the surface of C. jejuni cells (Nachamkin, 2002; Winer, 2001).  
C. jejuni contain a lipopolysaccharide structure (LPS) attached to the outer membrane, 
the core oligosaccharides of its LPS contain ganglioside-like structures which are similar to 
certain human gangliosides (Ang et al., 2001; Perez and Blaser, 1985; Logan and Trust, 1982). 
The LPS structure is highly antigenic and upon exposure to C. jejuni, the immune system 
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produces antibodies against the LPS structure as an attempt to fight the infection. Due to the 
similarity of the core oligosaccharides of the LPS and the gangliosides, after the infection, 
antibodies attack the gangliosides on the neuromuscular junction contributing to the appearance 
of neurological symptoms (Godschalk et al., 2004; Ang et al., 2001; Lindsay, 1997).  
2.3 CAMPYLOBACTER SPP. IN POULTRY  
Campylobacter spp. have been recovered from rivers, coastal waters, shellfish, and 
vegetables but are routinely found in sheep, cattle, swine, rodents and poultry (Jacobs-Reitsma, 
2000; Kemp et al., 2005). Poultry are the most common hosts for Campylobacter spp. and is 
considered the main source of human illness (Mackiw et al., 2008; Vellinga and Van, 2002). 
More specifically, approximately 70% of human illnesses due to Campylobacter spp. are caused 
by the consumption or handling of raw or undercooked poultry or poultry products (Friedman et 
al., 2000; Mead et al., 1999). Increased attention has been given to reducing the level of 
Campylobacter spp. in poultry pre- and post-harvest to reduce the level and incidence of raw 
product contamination (Friedman et al., 2004; Keener et al., 2004; Allos, 2001). The decimal 
reduction time for Campylobacter spp. varies depending on the type of food product but survival 
kinetics generally involve a rapid decline in numbers followed by a slower rate of inactivation. 
This may explain the increased survival rate of Campylobacter spp. on poultry carcasses due to 
the high levels of the organisms in the digestive tract at the time of processing. The potential for 
survival decreases to a few hours at temperatures of 37ºC and increases to a few days at 
temperatures of 42ºC.  
Prevalence of Campylobacter spp. in food animals can exceed 80% thus challenging 
processors to employ post-harvest pathogen reduction strategies (Corry and Atabay, 2001; Sahin 
et al., 2002). The prevalence of Campylobacter spp. appears to vary by both species and country 
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(Newell and Fearnley, 2003). In the United States, the prevalence of Campylobacter spp. in 
commercial broilers ranges from 20-90% (Shane, 2000; Stern et al., 2001). In Canada and South 
America, the prevalence of Campylobacter spp. in commercial broilers ranges from 45-48% and 
20-96%, respectively (Aho and Hirn, 1988; Newell and Fearnley, 2003; Shane, 2000). In Europe, 
the proportion of commercial broiler flocks colonized with Campylobacter spp. varies from 2.9% 
to more than 92% (Bouwknegt et al., 2004; Evans and Sayers, 2000; Hald et al., 2000; Heuer et 
al., 2001) with the lowest flock prevalence (2.9%) observed in Finland (Perko-Makela et al., 
2002). In other regions, the prevalence of Campylobacter spp. within commercial broiler flocks 
ranges from 13.6% to 87% in Africa (Cardinale et al., 2004), 24% to 54% in Asia (Newell and 
Fearnley, 2003), and approximately 42% in Australia (Saleha et al., 1998).  
A significantly high prevalence rate of Campylobacter spp. contamination can be found 
in retail poultry and poultry products and is often directly related to the prevalence rate at the 
farm (Skovgaard, 2007). The average prevalence rate of infected flocks is 44-59% with a range 
of 3-100% (Nauta and Havelaar, 2008; Humphrey et al., 2007). The number of contaminated 
broilers accounts for the high incidence of Campylobacter spp. in poultry processing plants and 
on processed birds (Lindqvist and Lindblad, 2008; Allen et al., 2007). The average 
Campylobacter spp. prevalence rate on chicken at retail is 57% with a range of 23% to 100% 
(Humphrey et al., 2007).  
Among Campylobacter-positive flocks, C. jejuni was the predominant species in poultry 
especially in commercial broilers. Many studies on the prevalence of Campylobacter spp. in 
commercial broilers have shown that 85- 98% of commercial broiler flocks were colonized by     
C. jejuni whereas, about 2-11% and 1-5% were colonized by C. coli and C. lari, respectively 
(Avrain et al., 2003; Evans and Sayers, 2000; Jorgensen et al., 2002).  
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2.4 SOURCES OF POULTRY FLOCK COLONIZATION 
 
Several risk factors can be linked to colonization and transmission of Campylobacter spp. 
in broiler flocks such as vertical transmission (eggshell samples from hatcheries) and horizontal 
transmission (age of birds, drinking water, feed samples and equipment swabs: enclosures, 
troughs) (Hiett et al., 2002; Berndtson et al., 1996a; Jones, 2001; Sahin et al., 2002).  
The vertical transmission of C. jejuni from hen to chick is a controversial theory that 
states that the bacterium can infect fertile hatching eggs and at hatch, the chicks carry this 
organism. For example, studies have shown that C. jejuni could be isolated from the outer and 
inner surface of egg shells laid by naturally infected commercial layers or broiler breeders 
(Doyle, 1984; Shanker et al., 1986). Investigations on vertical transmission have shown that      
C. jejuni potentially may enter the eggshell (Sahin et al., 2003a). 
Doyle (1984) reported that C. jejuni can penetrate the outer membranes of refrigerated 
table eggs but did not find that it penetrated into the egg contents. Neill et al. (1985) 
demonstrated that C. jejuni can penetrate into the egg but they did not find that   C. jejuni had 
infected the albumin or yolk.  Shanker et al. (1986) reported that from the hen, C. jejuni can 
penetrate into the inner membranes of eggs. Chaudhary et al. (1989) found that C. jejuni could 
penetrate the inner and outer membranes and the egg contents of cracked eggs. From eggs 
obtained from actively shedding broiler breeders and from a commercial hatchery, Sahin et al. 
(2003a) detected no Campylobacter spp. From commercial breeder eggs, Acevedo (2005) found 
that 1.6% of the egg’s interiors and 3.8% of their surfaces were contaminated by Campylobacter 
spp.  
Horizontal transmission is also a potential avenue of flock contamination. A single 
transmission route in flock contamination has not been identified (Ellis-Iversen et al., 2011; 
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Ridley et al., 2011). Potential sources of horizontal flock infection include age of birds, used 
litter, untreated drinking water, domestic pets, wildlife species, house flies, insects, farm 
equipment, workers and transport vehicles (Kazwala et al., 1990; Van de Giessen et al., 1992; 
Kapperud et al., 1993; Berndtson et al., 1996a; Jacobs-Reitsma, 1997; Evans and Sayers, 2000). 
However, none of these suspected sources has been conclusively identified as the source of 
infection for broiler farms.   
The age of the chicken plays a major role in horizontal transmission. The main 
colonization site of Campylobacter spp. in chickens is the mucus layer within the lower intestinal 
tract overlaying the epithelial cells in the ceca and cloacal crypts (Meinersmann et al., 1991). 
Colonization in broiler chickens is highest in the mucosal crypts of the caeca, but also occurs in 
the small intestine (Conlan et al., 2007). Campylobacter spp., once colonized within the digestive 
tract, can be found in levels up to 10
9
 CFU/g of fecal content (Altekruse et al., 1999). Once a 
broiler is colonized with Campylobacter spp., the organisms are usually present throughout the 
production cycle. Colonization of these sites in natural environments is not usually observed 
until 14 to 21 days (Evans and Sayers, 2000).  Previous studies found that the commercial broiler 
flocks under the age of 2 - 3 weeks old are rarely detected (Berndtson et al., 1996b; Engvall et 
al., 1986; Evans and Sayers, 2000; Jacobs-Reitsma, 1997; Newell and Fearnley, 2003; Sahin et 
al., 2002; Shane, 2000). Once infected, Campylobacter spp. has been found in up to 100% of 
birds tested in a given flock (Keener et al., 2004). Conlan et al. (2007) reported that chickens less 
than two weeks of age normally are not colonized due to a “lag phase” derived from maternal 
antibodies that are prevalent in young chicks. Normally the transmission of Campylobacter spp. 
results from fecal-oral transmission and can often contaminate the entire flock within 5 weeks 
(Keener et al., 2004; Jacobs-Reitsma et al., 1995). Birds aged 42 days tested 100% positive for 
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Campylobacter spp. whereas, birds aged 56 days showed a 90% infection rate (Northcutt et al., 
2003).  Berndtson et al. (1996b) found that the rate of positive flocks increased with age from 
week one to week five.  
Environmental sampling of feces is common for Campylobacter spp. detection and a 
number of different techniques exist (Keener et al. 2004). Eifert et al. (2003) compared to 
sampling techniques (fecal swabs vs. environmental surface “drag” samples) and found that 
environmental swabs of the litter yielded the highest percentage recovery. Other studies using 
fecal swabs reported similar results (Stern et al., 2002; Bull et al., 2006). 
In commercial poultry settings, water is usually not considered the initial source of 
contamination of broiler flocks but might play a role in cross-contamination (Lindblom et al., 
1986; Pearson et al., 1993). Campylobacter spp. can be transmitted by the fecal-oral route to 
water. Adult chickens consume about 0.05 to 0.16 gallons of water per day depending on 
temperature (Frame, 2008). Swab samples can be taken to test for the presence of Campylobacter 
in water. Positive samples as high as 88% were reported by Berndtson et al. (1996a). 
Additionally, they found 90 of 300 pooled swab samples from water lines (30%) tested positive 
for Campylobacter.  
Several studies have shown that contamination of water usually occurs after colonization 
of the flock rather than preceeding it (Engvall et al., 1986; Lindblom et al., 1986; Kazwala et al., 
1990). Non-chlorinated water including ground water is frequently used as a source for drinking 
water on poultry farms and has been implicated as the source of C. jejuni (Kapperud et al., 1993; 
Pearson et al., 1993). The presence of this bacterium in streams, rivers and groundwater might be 
a sign of recent contamination from livestock or wild birds (Houng et al., 2001). 
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In general, clean dry litter, enclosures, fresh feed and feed devices are not considered 
primary sources of Campylobacter spp. colonization in broilers (Berndtson et al., 1996a). 
Although the mode is often unclear, these sources can become cross-contamination vectors (Bull 
et al., 2006). For example, Johnsen et al. (2006) reported 25% (4/16) feed devices tested positive 
for Campylobacter spp.   
Flies, mice, and other pests have also been reported as colonization sources. For example, 
Stern et al. (2001) found 25% of insects caught outside of poultry houses to be Campylobacter-
positive. Berndtson et al. (1996b) showed that flies can act as carriers of C. jejuni for up to         
2 days after infection. Feces from vermin have also been reported as sources of contamination 
(Newell and Wagenaar, 2000). 
 Because Campylobacter spp. transmission to the poultry reservoir is not always clear, a 
variety of intervention strategies should be considered in its control. As the nature of 
transmission its complex, multiple approaches that target different segments of the poultry 
production system should be considered. 
2.5 ISOLATION AND IDENTIFICATION  
2.5.1 Isolation of Campylobacter spp. 
A number of Campylobacter spp. selective media have been used. These include blood-
free media such as modified charcoal cefoperazone deoxycholate agar (mCCDA), charcoal-
based selective medium (CSM), and Karmali agar. Blood-containing media such as Skirrow’s, 
Butzler’s, Blaser’s, Campy-BAP, Preston agar, and Campy CVA agar are used as well (Bolton et 
al., 2002; Corry, 2000; Mahon and Manuselis, 2000). Semi-solid blood-free selective motility 
medium is also used.  
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These selective media contain combinations of antibiotics to which thermophilic 
Campylobacter spp. are intrinsically resistant but other bacteria particularly enteric microbial 
flora are susceptible (Corry et al., 1995). Antimicrobial agents that are usually used in 
Campylobacter spp. selective media include a combination of cephalosporins such as 
cephalothin or cefoperazone and vancomycin or bacitracin. Although both cephalothin and 
cefoperazone have been used in Campylobacter spp. selective media, cefoperazone is preferred 
because some strains of C. jejuni such as C. jejuni subsp. Doylei, C. coli, C. fetus and                
C. upsaliensis are inhibited by cephalothin (Corry et al., 1995; Nachamkin et al., 1998).  
Because Campylobacter spp. are sensitive to oxygen, most selective media usually 
contain substances that help protect them from the toxic effect of oxygen derivatives (Corry, 
2000). The most commonly used substances for neutralizing these toxic oxygen derivatives 
include whole, lysed, or defibrinated blood; charcoal, a combination of ferrous sulfate, sodium 
metabisulfite, sodium pyruvate, haemin and haematin (Corry et al., 1995).   
In addition, enrichment broths have also been formulated to enhance the recovery rates of 
thermophilic Campylobacter spp. These enrichment broths are useful when low numbers of 
Campylobacter spp. are expected in the sample.  The most widely used enrichment broths for 
Campylobacter spp. include Preston, Doyle and Roman, Park and Sanders, Hunt and Radle, and 
Exeter (Bolton and Robertson, 1982; Corry et al., 1995; Corry, 2000; Doyle and Roman, 1982).  
Campylobacter spp. is isolated by a direct plating method or a selective enrichment 
method depending on the organism and the enumeration present in the sample (Sahin et al., 
2003b). For example, because feces or intestinal/cecal contents from chickens usually contain 
high numbers of Campylobacter spp. organisms, a selective enrichment method is appropriate.  
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To successfully isolate Campylobacter spp. from samples, selective media and optimal 
incubation conditions are crucial (Forbes et al., 1998). Campylobacter spp. are strictly 
microaerophilic. The ideal atmospheric environment for optimal recovery of Campylobacter spp. 
is 5% O2, 10% CO2, and 85% N2. In general, most laboratories use 42°C as the primary 
incubation temperature for Campylobacter spp. isolation (Nachamkin, 1999). This temperature is 
the optimal growth temperature of thermophilic Campylobacter including C. jejuni, C. coli, C. 
lari, and C. upsaliensis; however, it may not be suitable for the growth of several other 
Campylobacter species (Corry, 2000). In order to isolate thermophilic Campylobacter spp., the 
selective agar plates should be incubated between 37°C and 42°C for 24-48 hours under 
microaerophilic conditions.      If no Campylobacter spp. colonies are present on the plates, the 
incubation should be extended up to 96 hours before being reported as negative (Forbes et al., 
1998; Nachamkin, 1999). 
2.5.2 Identification of Campylobacter spp. 
 
Campylobacter spp. colonies appear differently depending on the media used. For 
example, colonies might appear gray to pinkish gray, non-hemolytic, flat and slightly mucoid 
(Forbes et al., 1998; Kaplan and Weissfeld, 1994; Nachamkin, 1999). When Campylobacter spp. 
are sub-cultured onto freshly prepared moist media, colonies appear along the streak line or 
swarm on the agar plate. As the moisture content decreases, Campylobacter colonies may 
become round, convex, and glistening with little spreading (Nachamkin, 1999; Shane and 
Montrose, 1985). Colony and microscopic morphology also are useful to identification of 
Campylobacter spp. (Rowe and Madden, 2000).  
Campylobacter spp. are gram-negative, curved-rod shaped bacteria that are 
approximately 0.2 to 0.5 μm wide and about 0.5 to 5 μm long (Mahon and Manuselis, 2000; 
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Rowe and Madden, 2000). Because Campylobacter spp. are not easily visualized with safranin 
counterstain, carbolfuchsin is used.  
Other phenotypic tests, especially oxidase and catalase tests, are used to confirm the 
identification of some Campylobacter spp. (Kaplan and Weissfeld, 1994, Sahin et al., 2003b). 
Other biochemical tests include hippurate hydrolysis, hydrogen sulfide (H2S) production in triple 
sugar iron agar butts, nitrate reduction, urease production, indoxyl acetate hydrolysis, 
cephalothin sensitivity, and nalidixic acid susceptibility (Forbes et al., 1998; Sahin et al., 2003b).  
Hydrolysis of sodium hippurate is the primary biochemical test used to differentiate C. 
jejuni from other thermophilic Campylobacter spp. This is because only C. jejuni can hydrolyze 
sodium hippurate (Blaser, 2000; Sahin et al., 2003b).  
Newer techniques have been developed for rapid detection and identification of 
Campylobacter species. Techniques based on antigen-antibody interactions include latex 
agglutination tests, enzyme immunoassays (EIA), enzyme-linked immunosorbent assay 
(ELISA), immunoblotting, colony blotting, colony lift immunoassay (CLI) and immunomagnetic 
separation (IMS). Techniques based on deoxyribonucleic acid (DNA) detection include DNA 
hybridization assays and polymerase chain reaction (PCR) (Sahin et al., 2003b).  
2.5.3 Latex Agglutination Immunoassay 
As state previously, latex agglutination tests are used for rapid identification and 
confirmation of Campylobacter spp. (Hazeleger and Beumer, 2000; Mahon and Manuselis, 
2000). The tests identify Campylobacter spp. at the generic level but not the species (Hazeleger 




Latex agglutination tests are usually performed after the primary isolation of thermophilic 
Campylobacter spp. They are not intended for direct detection of Campylobacter spp. from field 
samples (Hazeleger and Beumer, 2000; Mahon and Manuselis, 2000; Sahin et al., 2003b). 
Examples of the commercially available latex agglutination test kits include Campyslide (BBL 
Microbiology Systems, Cockeysville, MD), Meritec Campy (Meridian Diagnostics, Cincinnati, 
OH), ID Campy (Integrated Diagnostics, Baltimore, MD), INDX-Campy (PanBio INDX, Inc., 
Baltimore, MD), and Microscreen Campylobacter (Mercia Diagnostics, Guildford, UK) 
(Hazeleger and Beumer, 2000). Most of these test kits can detect C. jejuni, C. coli, and C. lari 
(Mahon and Manuselis, 2000). Some of these tests also can detect C. fetus and C. upsaliensis. 
Instructions on the use of this test have been published by Hazeleger and Beumer (2000).  
2.6 ANTIMICROBIAL USE IN POULTRY PRODUCTION  
Antimicrobials in poultry production are used to enhance growth, control natural spoilage 
processes and prevent or control the growth of pathogenic microorganisms (Tanner, 2000; 
Tajkarimi et al., 2010). Generally, poultry carry C. jejuni asymptomatically and shed the 
bacterium in their feces. Several studies have addressed the use and efficacy of antibiotics on an 
array of poultry infections including Campylobacter spp. and C. jejuni. For the most part, the 
results are mixed. For example, the in vivo study by Caravalho et al (2010) found that a three-
phage lytic cocktail administered to chickens resulted in a 2 log CFU/g reduction in C. jejuni. In 
another in vivo study using turkeys, Scupham et al. (2010) found that the administration of 
enrofloxacin, neomycin and vancomycin resulted in a respective decrease of 1, 2 and 4 log 
CFU/g in C. jejuni.  Robyn et al. (2013) attempted to inhibit C. jejuni in chickens through the 
administration of live bacterium Enterococcus faecalis.  As they reported, this bacterium failed 
to inhibit the growth of C. jejuni.  
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Although there are multiple levels at which Campylobacter spp. contamination can be 
targeted, on-farm control has the greatest impact because the living poultry intestine is the 
primary amplification point throughout the food chain (Wagenaar et al., 2006; Wagenaar et al., 
2008).  
2.6.1 Use of Sulfonamides  
The general term sulfonamide refers to any derivative of sulfanilamide. Sulfonamides are 
structural analogues of para-aminobenzoic acid (PABA) and compete with PABA for the 
enzyme dihydropteroate synthetase (DHPS). This action prevents PABA from becoming 
incorporated into folic acid, a necessary cellular component. Resistance to sulfonamide in Gram-
negative bacteria is normally due to the acquisition of drug-resistant variant of DHPS. This 
resistance has been shown to be transferred horizontally among isolates (Radstrom et al., 1991). 
In Gram-positive bacteria the most common mechanisms are mutations in the gene encoding 
DHPS (Swedberg et al., 1998).  
Sulfonamides have been used to treat a wide range of infectious diseases in humans and 
animals including pneumonia, meningitis, malaria, and urinary tract infections. Their broad 
spectrum of activity rivals that of the tetracyclines. They are used alone or in combination with 
trimethoprim. Trimethoprim inhibits the reduction of dihydrofolic acid (DHF) to tetrahydrofolic 
acid (THF) by binding to bacterial dihydrofolic acid reducatase (DHFR) (Roland et al., 1979). 
Sulfonamides decrease the de novo synthesis of DHF while trimethoprim decreases the 
conversion of new and recycled DHF to THF. Combination of the two drugs results in a 
synergistic sequential blockade (Swedberg et al., 1979). 
In humans, adverse reactions to sulfonamides are relatively common and can occur from 
direct toxicity or hypersensitivity (Stowe, 1965). Although not a prominent effect, sulfonamides 
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can produce disturbances in gastrointestinal flora due to their broad spectrum of activity. The 
most common symptoms are anorexia, nausea and vomiting which occurs in 1% to 2% of 
patients. Disturbances of the urinary tract, including renal crystalluria, can occur while taking 
sulfonamides if fluid intake is low. Sulfonamides can cause hypothyroidism by impairing 
thyroglobulin iodination and coupling of tyrosinases. Hypersensitivity reactions including fever, 
itching, and skin rashes can occur in up to 3% of patients (Bevill and Huber, 1977).  
In poultry, sulfonamides were first used to treat upper respiratory (Delaplane, 1945) and 
coccidial infections caused by Eimeria tenella and Eimeria necatrix (Grumbles and Delaplane, 
1948, Waletzky and Hughes, 1946). The commonly used sulfonamide in poultry production is 
sulfadimethoxine and therefore it appropriate for in vivo testing.  
2.6.2 Effects of Sulfadimethoxine on C. jejuni  
According to US Food and Drug Administration (2013), sulfadimethoxine is an antibiotic 
that has been administered in commercial poultry production to treat a variety of infections. 
These include the respiration illnesses, coccidiosis, fowl cholera, and coryza (Vree and Hekster, 
1987; Wang et al., 2012). 
To date, there have been no in vivo studies on the efficacy of sulfadimethoxine in the 
control of C. jejuni in broilers. Although largely unknown, the positive potential effects of 
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PREVALENCE AND DISTRIBUTION OF CAMPYLOBACTER JEJUNI 
IN SMALL-SCALE BROILER OPERATIONS 
 
3.1 INTRODUCTION  
Campylobacter jejuni is a common foodborne bacterial pathogen of humans in the United 
States and other developed countries. The infection caused by this organism is characterized by 
self-limiting watery and bloody diarrhea (Altekruse et al., 1999; Friedman et al., 2000; Skirrow 
and Blaser, 2000). The majority of human Campylobacter infections result from consumption of 
undercooked chicken or food contaminated by raw chicken (Stern, 1992; Altekruse et al., 1999; 
Friedman et al., 2000). In 2013, FoodNet identified 19,056 laboratory-confirmed cases of human 
Campylobacter infection. The number of infections and incidence per 100,000 populations by 
Campylobacter are 6,621 and 13.82 respectively. Of these infected populations, 1,010 people 
(15%) were hospitalized and 12 people (0.2%) died from food contaminated by Campylobacter 
(FoodNet, 2013). The estimated incidence of infections caused by Campylobacter was 14% 
higher in 2012 compared with 2006-2008 (FoodNet, 2012). An estimated 2.1–2.5 million cases 
of human campylobacteriosis occur annually in the USA (Blaser, 1997; Altekruse et al., 1999; 
Friedman et al., 2000).  
Campylobacter jejuni infects a variety of wild and domestic animals and birds. 
Commercial poultry is considered the major reservoir of human Campylobacter infections 
(Friedman et al., 2000). Therefore, reduction of C. jejuni levels in the poultry production system 
is essential to public health. In order to reduce or eliminate Campylobacter spp. from poultry, it 
is necessary to understand the ecological aspects of the infection in the reservoir. On-farm 
production practices can affect pathogen loads on poultry entering slaughter facilities, resulting 
in cross contamination post-harvest. For the past several decades, a large number of farm-based 
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studies have been performed to determine the epidemiological features of C. jejuni infections 
(Shane, 1992; Stern, 1992; Friedman et al., 2000; Newell and Wagenaar, 2000).  
Campylobacter jejuni is highly prevalent in chicken flocks, especially in chickens more 
than 3 weeks old. The organism is carried in poultry intestinal contents in high amounts, leading 
to fecal contamination of chicken carcasses in processing plants (Shane, 1992; Stern, 1992; 
Newell and Wagenaar, 2000). Despite this high colonization rate, infected chickens show little or 
no clinical signs of illness (Shane, 1992; Stern, 1992). Sources of infection and modes of 
transmission for C. jejuni infection in poultry farms are not well understood. Many studies 
suggest that horizontal transmission from environmental sources is the major mode of chicken 
flock infection by C. jejuni (Clark and Bueschkens, 1988; Stern, 1992; Pearson et al., 1993; 
Jacobs-Reitsma et al., 1995; Newell and Wagenaar, 2000). However, several findings suggest 
that vertical transmission might also play a role in introducing C. jejuni from breeders into 
broiler flocks (Doyle, 1984; Shane et al., 1986; Pearson et al., 1993; Chuma et al., 1997). The 
complexity of Campylobacter transmission and the extensive nature of the colonization might 
undermine the effectiveness of management-based intervention measures. This problem 
highlights the need for alternative strategies, such as vaccination, to control C. jejuni infection in 
the poultry reservoir and consequently reduce the risk of human campylobacteriosis (Sahin et al., 
2002).  
Currently, the ecology of Campylobacter spp. in the poultry reservoir is poorly 
understood, particularly with respect to the sources of infection and routes of transmission. It is 
thought that both vertical and horizontal transmission may affect the immune status of the 
poultry host and the environmental conditions in the production system (Ridley et al., 2011; 
Ellis-Iversen et al., 2012). Intervention strategies for Campylobacter spp. infection in poultry 
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should consider the complex nature of its transmission and may require the use of multiple 
approaches that target different segments of the poultry production system (Irene et al., 2010). 
However, most studies have concentrated on the transmission routes from commercial farm flock 
to carcasses after slaughter and retail products (Dickins et al., 2002; Takahashi et al., 2006; 
Lienau et al., 2007; Praakle-Amin et al., 2007; Ellerbroek et al., 2010). Interest in animal welfare 
issues has spurred an increased interest in free range, small scale, and local poultry production. 
With these open air, less controlled environments an increased infection rate of Campylobacter 
spp. might be an issue. Therefore, there is a need to control infection rates and identify potential 
cross contamination vectors associated with small-scale poultry production.   
The objectives of these experiments are severalfold. One objective is to determine the 
enumeration of Campylobacter spp. and the prevalence on both Campylobacter spp. and           
C. jejuni on the shells of eggs received from the hatchery during incubation. A second objective 
is to detect the presence and extent of Campylobacter spp. and C. jejuni in live birds raised in the 
battery-cage and the cage-free systems over a six week period. A third objective is to determine 
whether and to what extent Campylobacter spp. and C. jejuni are present in the drinking water, 
feed, enclosures and troughs of the experimental birds. This research effort might help improve 
the development of risk management strategies in the industry. Ultimately, these findings might 
help reduce the risks associated with campylobacteriosis to the consumer. 
3.2 MATERIALS AND METHODS  
 
3.2.1 Sample Collection 
3.2.1.1 Developing Eggs 
Ninety six incubating eggs housed at the McNeese State University Agricultural Sciences 
laboratory in Lake Charles, Louisiana were evaluated for C. jejuni. Each week, seventy five 
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eggshells were randomly swabbed using a Sterile Rayon Tipped swab. The sample swabs were 
placed in individual tubes containing 3 ml of sterile tryptone soya broth (TSB) for enumeration 
and isolation of Campylobacter spp. for 3 weeks until hatching. 
3.2.1.2 Broiler Production 
Two replications each using 150 broiler chickens (Ross × Ross) obtained from the 
McNeese State University Research Farm in Lake Charles, Louisiana were conducted. Birds 
were raised under two different production systems: the Petersime
® 
battery-cage system (32C) 
with raised wire flooring and the cage-free system with covered pen and wood shavings. The 
Petersime
® 
battery-cage system was divided into 12 pens of equal size (29.4” x 39” x 9.5”). Each 
pen housed six or seven birds. Individual water and feed troughs were provided for each pen. 
Feed was procured from the Texas Farm Products Company. This feed contains 18% protein 
chick grower crumbles and no antibiotics. For each replication, 75 broilers were placed in the 
cage-free system (150.5” x 202” x 100”). In the cage-free system, drinking water and feed were 
provided by a single waterer and feeder. Heat lamps were suspended 0.4 m above the litter for 
temperature regulation. For the battery-cage and the cage-free systems, drinking water and feed 
were supplied free-choice.  
Each week, individual chickens from the battery-cage and the cage-free systems were 
randomly sampled using Sterile Rayon Tipped Swabs. The sample swabs were placed in a tube 
containing 3 ml of sterile tryptone broth (TSB) for further analysis.  
3.2.1.3 Environment Samples 
One hundred forty four samples were randomly collected from drinking water, feed and 
equipment (enclosures and troughs) for two replications from September, 2013 to February, 
2014. Approximately 3-5 g per feed sample and 5-10 ml of drinking water per sample were 
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collected from the feed troughs and water troughs and placed in sterile bottles. Surface areas of 
enclosures and troughs were swabbed and immediately placed into tubes containing 3 ml of 
TSB.  
Chicken feces and environment samples were collected using aseptic techniques in sterile 
containers and were transported to the lab and analyzed at week 1, 2, 3, 4, 5 and 6. Quantitative 
concentration of Campylobacter spp. was determined using the method described by Corry et al. 
(2003). Isolation of Campylobacter spp. in the samples was done using Latex Agglutination tests 
(Moore et al., 2005; Miller et al., 2008).  
3.2.2 Bacterial Isolation and Identification  
Immediately upon arrival in the laboratory, the swab samples were whirl-mixed in           
a shaker incubator (New Brunswick Scientific Excella™ E24/E24R Temperature-Controlled 
Benchtop Shaker) for approximately 1 h at 37C and then mixed with a vortexer for 2 min to 
release the bacteria. Each 0.1 ml of swab sample was aseptically transferred and directly streaked 
onto modified charcoal cefoperazone deoxycholate agar (mCDDA). The inoculated plates were 
then incubated at 42C for 48 h under a microaerophilic environment (5%O2, 10%CO2, and 
85%N2). Verification of Campylobacter spp. isolated from the sample was done by Latex 
agglutination tests with a Microgen M46 Campylobacter Assay Kit (Microgen Bioproducts Ltd., 
Camberley, Surrey, United Kingdom). In addition, a hippurate hydrolysis test was performed to 
confirm C. jejuni (Hwang and Ederer, 1975).  
3.2.3 Campylobacter Latex Agglutination Kit 
The Microgen Kit is composed of F46a (Test Latex Reagent): latex particles coated with 
rabbit antibodies to Campylobacter antigens, F46b (Control Latex Reagent): latex particles 
coated with non-specific rabbit immunoglobulins, F46c (Positive Control): suspension of 
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inactivated Campylobacter antigens reactive with test latex reagent and non-reactive with control 
latex reagent, and F40 (0.85% Isotonic Saline).  
All reagents were allowed to reach room temperature and gently shaken to ensure a 
homogeneous suspension. One drop (50 L) of isotonic saline (F40) was dispensed to each of 
the two ovals of the agglutination slide. An inoculating loop was used to remove several colonies 
with Campylobacter-like morphology. Bacteria were mixed into each of the two drops of 
isotonic saline (F40) on the slide to form an even suspension. One drop (50 L) of Control Latex 
reagent (F46b) was added to one of the bacterial suspensions on the slide. One drop (50 L) of 
Test Latex Reagent (F46a) was similarly dispensed to the other bacterial suspension. The 
bacterial suspensions were mixed with latex reagents using a mixing stick with the Control Latex 
Reagent (F46b). The mixtures were spread to the edges of the oval areas. The slide was gently 
rocked to keep the fluid suspensions in constant movement for 2 min to produce agglutination. 
Strength of the reaction is variable and was assessed according to the following: + reaction: fine, 
but readily discernible granularity against a milky background, ++ reaction: coarse granularity 
against a milky background, and +++ reaction: heavy clumping of particles around the periphery 
of the test oval, against a clear background. 
3.2.4 Hippurate Hydrolysis Test 
This test is used to determine whether a microorganism, by action of the enzyme 
hippurate hydrolase, can hydrolyze sodium hippurate to benzoic acid and glycine. The glycine 
end product is detected by the addition of ninhydrin reagent and through a complex reaction 
forms a deep purple color that can be easily visualized for the identification of C. jejuni.  
A 1% aqueous solution of sodium hippurate was prepared and dispensed in 0.4 ml 
amounts into 0.2 ml centrifuged tubes. Inoculum from 24 h of Campylobacter growth of the test 
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organism was emulsified into a tube of the hippurate solution and incubated in a 37°C for 2 h. 
After incubation, 0.2 ml of the ninhydrin solution was carefully added down the side of the tube 
to form an overlay over the cell mixture so not to mix the solutions. Samples were incubated for 
10 minutes and observed. A deep purple-blue result indicated a positive test for C. jejuni. A 
colorless result indicated a negative result for the presence of C. jejuni. 
3.2.5 Statistical Analysis 
Statistical procedures were performed using SAS Windows (SAS Institute, 2003).          
A block design with two replications was randomly assigned to two environmental conditions of 
chicken production. All calculations were performed with Proc GLM procedures (SAS, 2003) 
using P=0.05 for significance of Least Squares Means and simple correlation coefficients among 
variables with a model of chicken production environmental condition and period time testing. 
When treatment difference is detected, specific comparisons between treatment means at that 
time point were made with the PDIFF option of LSMEANS. 
3.3 RESULTS AND DISCUSSION  
3.3.1 Egg Samples 
Seventy five egg surface swabs were tested for Campylobacter spp. and C. jejuni during 
the three week incubation period. No Campylobacter spp. and C. jejuni growth was detected 
(0/75 tests). These results are consistent with those of Sahin et al. (2003) who reported no 
Campylobacter spp. in samples of 500 eggs obtained from actively shedding broilers or of 1,000 
eggs obtained from a commercial hatchery. It has been proposed that the vertical transmission of 
Campylobacter spp. from eggs to broilers might be due to abiotic factors. These results suggest 
that the possibility of vertical transmission of Campylobacter spp. and C. jejuni specifically from 
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the surface of eggs to newly hatched chicks is not a significant risk factor in small commercial 
settings.  
3.3.2 Environment Samples 
3.3.2.1 Drinking Water  
An important potential source of outbreaks of Campylobacter gastroenteritis is 
contaminated water. The presence of Campylobacter spp. in drinking water stations has been 
reported in other studies. For example, Berndtson et al. (1996) found the presence of 
Campylobacter spp. in broiler house drinking water samples as high as 88%.  
This study tested for the presence of Campylobacter spp. in drinking water from the 
battery-cage and the cage-free systems. Campylobacter spp. counts in drinking water from the 
battery-cage system ranged from 0 to 2.10 log CFU/ml and from the cage-free system ranged 
from 0 to 3.05 log CFU/ml (Figure 3.1). The counts of Campylobacter spp. in drinking water 
stations steadily increased from week 1 to week 6 from the battery-cage and the cage-free 
systems (Figure 3.1).  
The prevalence of Campylobacter spp. in drinking water ranged from 0% (0|144 samples) 
to 66.67% (96|144 samples) in the battery-cage system and ranged from 0% (0|144 samples) to 
76.39% (110|144 samples) in the cage-free system (Table 3.1).  
Additionally, the specific prevalence of C. jejuni through hippurate hydrolysis in drinking 
water samples ranged from 0% (0|144 samples) to 20.14% (29|144 samples) in the battery-cage 
system and from 0% (0|144 samples) to 76.39% (110|144 samples) in the cage-free system 
(Table 3.1). The results of this study clearly show that the prevalence of C. jejuni in drinking 
water samples was significantly higher (P<0.05) in the cage-free system (76.39%; 110|144 




Figure 3.1 Campylobacter spp. bacterial counts in drinking water samples from the battery-cage 
and the cage-free systems from weeks 1 through 6. Data are means from two replications.  
a,b
Treatment means with different superscripts for the same week are significantly different, 
P<0.05.  SEM = 1.7784. 
 
Table 3.1 The prevalence of Campylobacter spp. and C. jejuni in drinking water samples from 
the battery-cage and the cage-free systems from weeks 1 through 6.  
 
Week 
No. (%) of positive samples of 
Campylobacter spp. (n = 144) 
No. (%) of positive samples of  
C. jejuni (n = 144) 
























































ND = Non detectable. Data are means from two replications. 
a,b
Treatment means with different 
superscripts for the same week are significantly different, P<0.05. SEM for Campylobacter spp. 
= 0.0747; SEM for C. jejuni = 0.0680. 
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Drinking water supplied to chickens in the cage-free system is through a single 
communal system. This type of system lies in close proximity to the soil. Therefore, drinking 
water in this system can easily become contaminated by chicken feces and other pollutants. 
Under these conditions, sediments and biofilms may form that serve as an environmental 
reservoir for Campylobacter spp. and C. jejuni. Cross contamination from this environment to 
broilers is a distinct possibility. As noted by Pearson et al. (1993) and Lindblom et al. (1986) 
drinking water is usually not the primary source of Campylobacter spp. and C. jejuni 
contamination but might subsequently contribute to cross-contamination.  
These findings suggest that the drinking water used in chicken production, especially in 
the cage-free system, should be clean and free of chicken feces that can help sustain the growth 
of Campylobacter spp. and C. jejuni. Routine monitoring of the drinking watering system must 
occur frequently. Having fewer birds per drinking water trough may reduce the enumeration of 
Campylobacter spp. and the prevalence of Campylobacter spp. and C. jejuni. 
3.3.2.2 Feed 
Due to its low moisture content, fresh feed is an unlikely primary source of 
Campylobacter (Berndtson et al., 1996). However, feed subsequently can be contaminated from 
other sources such as feces (Shreeve et al., 2000) and can play a role in the transmission through 
cross-contamination of C. jejuni to broilers. In this study, fresh feed from each bag was tested for 
Campylobacter spp. and C. jejuni before it was fed to the broilers. Neither Campylobacter spp. 
nor C. jejuni was detected. Subsequently, Campylobacter spp. counts from feed samples during 
the six-week period of this study ranged from 0-2.10 log CFU/ml in the battery-cage system and 




Figure 3.2 Campylobacter spp. bacterial counts in feed samples from the battery-cage and the 
cage-free systems from weeks 1 through 6. Data are means from two replications.  
a,b
Treatment means with different superscripts for the same week are significantly different, 
P<0.05. SEM = 1.6439. 
 
The prevalence of Campylobacter spp. from feed samples in the battery-cage system 
ranged from 0% (0|144 samples) to 83.33% (120|144 samples) and 0% (0|144 samples) to 
35.42% (51|144 samples) in the cage-free system (Table 3.2). 
Additionally, the prevalence of the specific bacterium, C. jejuni, ranged from 0% (0|144 
samples) to 33.33% (48|144 samples) from feed samples in the battery-cage system and from 0% 
(0|144 samples) to 35.42% (51|144 samples) in the cage-free system (Table 3.2). The results of 
this study suggest that feed had become cross-contaminated by Campylobacter spp. and            







Table 3.2 The prevalence of Campylobacter spp. and C. jejuni in feed samples from the battery-
cage and the cage-free systems from weeks 1 through 6.  
 
Week 
No. (%) of positive samples of 
Campylobacter spp. (n = 144) 
No. (%) of positive samples of 
C. jejuni (n = 144) 
























































ND = Non detectable. Data are means from two replications. 
a,b
Treatment means with different 
superscripts for the same week are significantly different, P<0.05. SEM for Campylobacter spp. 
= 0.0781; SEM for C. jejuni = 0.0573. 
 
As with the water supply, it is imperative to maintain clean feed when producing broilers 
in order to prevent cross-contamination. To that end, fresh dry feed, stored in closed containers, 
should be used. Feed bins should be periodically disinfected with a 10% chlorine bleach solution 
(Lacy and Czarick, 1992). Additionally, feed should not be supplied in overabundance so that it 
becomes fallow. 
3.3.2.3 Enclosures 
In this study, enclosures were randomly sampled for the presence of Campylobacter spp. 
and C. jejuni. Because the bacterium cannot survive on dry surfaces, enclosures typically are not 
considered primary sources of Campylobacter colonization. However, enclosures can become 
contaminated from feces of vermin (Newell and Wagenaar, 2000). A total of 144 enclosure 
samples for two replications were swabbed from the battery cage and the cage-free systems. 
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Campylobacter spp. counts were detected on the surface of enclosures in both the battery-cage 
and the cage-free systems. During the six-week period of testing, Campylobacter spp. counts 
from enclosure samples ranged from 0-1.30 log CFU/ml in the battery-cage system and from 0-
2.34 log CFU/ml in the cage-free system (Figure 3.3). 
 
Figure 3.3 Campylobacter spp. bacterial counts from enclosure samples from the battery- cage 
and the cage-free systems from weeks 1 through 6. Data are means from two replications.  
a,b
Treatment means with different superscripts for the same week are significantly different, 
P<0.05. SEM = 1.3931.  
 
In this study, the prevalence of Campylobacter spp. was not found in weeks 1, 2, 5, and 6 
in the battery-cage and the cage-free systems (Table 3.3). However, the prevalence of 
Campylobacter spp. was found during the third week at 16.67% (24|144 samples) in the battery-
cage system and during the fourth week at 58.33% (84|144 samples) in the cage-free system 
(Table 3.3). Additionally, through hippulate hydrolysis, the prevalence of specific bacterium      
C. jejuni was not found in the battery-cage system. However, C. jejuni was found in the cage-




Table 3.3 The prevalence of Campylobacter spp. and C. jejuni from enclosure samples from the 
battery-cage and the cage-free systems from weeks 1 through 6.  
 
Week 
No. (%) of positive samples of 
Campylobacter spp. (n = 144) 
No. (%) of positive samples of  
C. jejuni (n = 144) 
























































ND = Non detectable. Data are means from two replications. 
a,b
Treatment means with different 
superscripts for the same week are significantly different, P<0.05.  SEM for Campylobacter spp. 
= 0.0557; SEM for C. jejuni = 0.0324. 
 
It is uncertain as to why the enclosures in each setting showed evidence of 
Campylobacter contamination for only one week during the six weeks of testing. Although this 
may appear to be an anomaly, the presence of Campylobacter on enclosures, even for a short 
period of time can have major consequences. That is, cross-contamination, as with drinking 
water and feed, can occur rapidly through this vector. Therefore, regular sanitation practices 
designed to clean and disinfect cages should be employed. Specifically, the application of 
Nolvasan Solution, which contains chlorhexidine diacetate, is the standard for routine cleaning 
and disinfecting in small-scale poultry operations.  
3.3.2.4 Troughs 
One hundred forty four trough samples were swabbed from the battery-cage and the 
cage-free systems for two replications. Campylobacter spp. counts in this study ranged from     
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0-1.55 log CFU/ml in the battery-cage system and from 0-2.26 log CFU/ml in the cage-free 
system (Figure 3.4).  
 
Figure 3.4 Campylobacter spp. bacterial counts from trough samples from the battery-cage and 
the cage-free systems from weeks 1 through 6. Data are means from two replications. 
a,b
Treatment means with different superscripts for the same week are significantly different, 
P<0.05. SEM = 1.7571. 
 
These data indicate that levels of Campylobacter spp. in the troughs were relatively low. 
In this study, the prevalence of Campylobacter spp. was not detected from trough samples in the 
battery-cage system during weeks 1, 3, 5 and 6 but was detected in weeks 2 and 4 at 66.67% 
(96|144 samples) and 47.22% (68|144 samples) respectively (Table 3.4). Campylobacter spp. 
was not detected from trough samples in the cage-free system in weeks 1, 5, and 6 but was 
detected in weeks 2, 3 and 4 at 16.67% (24|144 samples), 25.0% (36|144 samples) and 17.36% 
(25|144 samples) respectively (Table 3.4). Additionally, the specific bacterium C. jejuni was 
detected from trough samples in weeks 3 and 4 in the cage-free system at 25% (36|144 samples) 
and 11.81% (17|144 samples) respectively (Table 3.4). The prevalence of C. jejuni from trough 
samples was not detected in the battery-cage system.  
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Table 3.4 The prevalence of Campylobacter spp. and C. jejuni from trough samples from the 
battery-cage and the cage-free systems from weeks 1 through 6.  
 
Week 
No. (%) of positive samples of 
Campylobacter spp. (n = 144) 
No. (%) of positive samples of 
C. jejuni (n = 144) 
























































ND = Non detectable. Data are means from two replications. 
a,b
Treatment means with different 
superscripts for the same week are significantly different, P<0.05.  SEM for Campylobacter spp. 
= 0.0661; SEM for C. jejuni = 0.0425. 
 
As is the case for drinking water, feed and enclosures described above, troughs can be a 
source for Campylobacter cross-contamination. Once again, the typical route appears to be from 
feces to beak. This problem may be more prevalent in the cage-free system than in the battery-
cage system. However, good sanitation practices are important in the battery-cage and the cage-
free systems. Again, the application of Nolvasan Solution is appropriate for routine cleaning and 
disinfecting in small-scale poultry operations.  
3.3.3 Live Broilers 
In chickens, Campylobacter colonizes the mucus overlying the epithelial cells primarily 
in the cecum and the small intestine. For sampling purposes, Campylobacter spp. is collected 
from feces (Newell and Fearnley, 2003). In this study, 150 individual chickens (75 from the 
battery-cage system and 75 from the cage-free system) were sampled for the presence of 
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Campylobacter spp. and C. jejuni for two replications. Using these protocols Campylobacter spp. 
and C. jejuni were successfully isolated. Each replication period extended for a period of six 
weeks, the time it takes for commercial farmers to raise, harvest and bring their birds to market.  
From enumeration tests, counts of Campylobacter spp. steadily increased from week 1 to 
week 6 in both the battery-cage and the cage-free systems. The counts of Campylobacter spp. in 
the battery-cage system increased from an initial value of 1.70 log CFU/ml in week one to a 
maximum value of 4.91 log CFU/ml in week six (Figure 3.5). In the cage-free system the initial 
value of 0 log CFU/ml in week one increased to a maximum value of 5.31 log CFU/ml in week 
six (Figure 3.5). 
 
Figure 3.5 Campylobacter spp. bacterial counts in live broilers from the battery-cage and the 
cage-free systems from weeks 1 through 6. Data are means from two experiments. 
a,b
Treatment 
means with different superscripts for the same week are significantly different, P<0.05. 
SEM = 3.2807. 
 
The counts of Campylobacter spp. in the cage-free system were materially higher than 
those of the battery-cage system (P<0.05) (Figure 3.5). As noted above, the presence of 
Campylobacter spp. in drinking water, feed, enclosures and troughs was elevated in the samples 
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taken in the cage-free system compared to those taken in the battery-cage system. As these are 
probable vectors in the cross-contamination of Campylobacter spp., it is reasonably postulated 
that these are contributing factors in the elevated levels of Campylobacter spp. contamination 
found in the cage-free birds. 
Prevalence tests were also performed during the six weeks of sampling.  For each of the 
test weeks, the prevalence of Campylobacter spp. in individual chickens from the battery-cage 
system ranged from 5.33% (8|150 samples) to 83.33% (125|150 samples) (Table 3.5).  
Table 3.5 The prevalence of Campylobacter spp. and C. jejuni in broilers from the battery-cage 
and the cage-free systems from weeks 1 through 6.  
 
Week 
No. (%) of positive samples of 
Campylobacter spp. (n = 150) 
No. (%) of positive samples of 
C. jejuni (n = 150) 
























































ND = Non detectable. Data are means from two experiments. 
a,b
Treatment means with different 
superscripts for the same week are significantly different, P<0.05.  SEM for Campylobacter spp. 
= 0.0228; SEM for C. jejuni = 0.0266. 
  
From the cage-free system, the prevalence of Campylobacter spp. ranged from 0% (0|150 
samples) to 93.33% (140|150 samples) (Table 3.5). These results indicated that the prevalence of 
Campylobacter spp. in individual broilers peaked during the third week. Specifically, there was a 
prevalence of 93.33% (140|150 samples) in the cage-free birds and 83.33% (125|150 samples) in 
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the battery-cage birds (Table 3.5). Other studies also have shown that the prevalence of 
Campylobacter spp. peaks and then declines over time. For example, Sahin et al. (2003) found 
similar results in their study of commercial chickens. Northcutt et al. (2003) posited that this 
decline might be due to maturation of antibodies passed from hens to their chicks. 
From additional testing via hippurate hydrolysis, the prevalence of the specific bacterium 
C. jejuni was detected. Specifically, the prevalence ranged from 5.33% (8|150 samples) to 50.0% 
(75|150 samples) in the battery-cage system and from 0% (0|150 samples) to 70.67% (106|150 
samples) in the cage-free system (Table 3.5). The prevalence of C. jejuni in week 6 was 
significantly higher (P<0.05) in the cage-free system (37.33%; 56|150 samples) than in the 
battery-cage system (26.0%; 39|150 samples) (Table 3.5). As stated previously, the elevated 
prevalence of C. jejuni in the drinking water, feed, enclosures and troughs in the cage-free 
system are probable contributing factors in the elevated levels of C. jejuni in those birds. Again, 
the application of Nolvasan Solution should substantially mitigate such cross-contamination.  
These results provide valuable base-line data concerning the presence and extent of 
Campylobacter in broilers raised in a small-scale poultry setting. This study next explores an 
avenue whereby Campylobacter infection in broilers is mitigated through the use of the 
antibiotic sulfadimethoxine. The details of these experiments are the subject of Chapter 4 of this 
dissertation.  
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THE EFFECTS OF SULFADIMETHOXINE ADMINISTERED TO CONTROL  
C. JEJUNI INFECTION IN SMALL-SCALE BROILER OPERATIONS 
 
4.1 INTRODUCTION  
Campylobacter spp. particularly Campylobacter jejuni is a common pathogenic cause of 
human foodborne gastroenteritis worldwide (Adak et al., 2005). Annually, approximately 400 
million cases of Campylobacter-associated gastroenteritis occur (Rao et al., 2001; Van et al., 
2001) with an economic impact estimated in excess of $2 billion (Allos, 2001). The European 
Union (EU), reported 214,268 confirmed cases of campylobacteriosis in 2012 at a cost of 2.4 
billion Euros (European Food Safety Authority, 2014). Havelaar et al. (2005) estimated that in 
the Netherlands with approximately 80,000 cases of gastroenteritis per year, the cost of illness 
caused by campylobacteriosis is about 21 million Euros.  
In the United States, Campylobacter spp. is responsible for an estimated 2.1-2.4 million 
cases of foodborne illnesses each year (Blaser, 1997; Altekruse et al., 1999; Friedman et al., 
2000; Samuel et al., 2004; Scallan et al., 2011) resulting in 13,000 hospitalizations, 100 deaths 
and an estimated cost of over $1 billion annually (Altekruse et al., 1999; Samuel et al., 2004; 
Anonymous, 2010). In 2013, FoodNet identified 19,056 laboratory-confirmed cases of human 
Campylobacter infection. The number of infections and incidence per 100,000 populations by 
Campylobacter are 6,621 and 13.82 respectively. Of these infected populations, 1,010 people 
(15%) were hospitalized and 12 people (0.2%) died from food contaminated by Campylobacter 
(FoodNet, 2013). 
Approximately 70% of human illnesses due to Campylobacter spp. are caused by the 
consumption or handling of raw or undercooked poultry (Friedman et al., 2000; Mead et al., 
1999). Additionally, Campylobacter spp. can be transmitted via contact with infected animals or 
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their feces. Many animals carry Campylobacter spp. asymptomatically and shed the bacterium in 
their feces. Poultry, particularly broiler chickens, also frequently harbor the bacterium.  
Because of the threat to public health, serious efforts are being made to prevent the 
colonization and spread of Campylobacter spp. and C. jejuni in poultry production (Allos, 2001; 
Friedman et al., 2004; Keener et al., 2004). A reduction in numbers of Campylobacter spp. and 
C. jejuni in poultry, production can lead to a corresponding reduction in human infections. 
Quantitative risk assessment models have indicated that a reduction of 2 log units on a broiler 
carcass could result in 30 times less prevalence of campylobacteriosis (Rosenquist et al., 2003). 
Therefore, reduction or elimination of Campylobacter spp. and C. jejuni in the poultry reservoir 
is an essential consideration in the control of this food safety problem. 
Although there are multiple levels at which Campylobacter spp. and C. jejuni 
contamination can be targeted, on-farm control of Campylobacter spp. and C. jejuni has the 
greatest impact because the living poultry intestine is the primary amplification point for 
Campylobacter throughout the food chain (Wagenaar et al., 2006; Wagenaar et al., 2008). 
Therefore, the use of various antimicrobial therapies to control Campylobacter spp. and C. jejuni 
infection in poultry production is worthy of exploration.  
Antimicrobial therapy is a potentially important tool in reducing the prevalence and 
enumeration of C. jejuni in poultry. Several studies have addressed the use and efficacy of 
antibiotics on an array of poultry infections including Campylobacter spp. and C. jejuni. For the 
most part, the results are mixed. For example, the in vivo study by Caravalho et al. (2010) found 
that a three-phage lytic cocktail administered to chickens resulted in a 2 log CFU/g reduction in 
C. jejuni. In another in vivo study using turkeys, Scupham et al. (2010) found that the 
administration of enrofloxacin, neomycin and vancomycin resulted in a respective decrease of    
54 
 
1, 2 and 4 log CFU/g in C. jejuni. Additionally, Robyn et al. (2013) attempted to inhibit C. jejuni 
in chickens through the administration of live bacterium Enterococcus faecalis. As they reported, 
this bacterium failed to inhibit the growth of C. jejuni.  
Sulfadimethoxine is an antibiotic administered in commercial poultry production to treat 
a variety of infections (Food and Drug Administration, 2013). These include the respiration 
illnesses, coccidiosis, fowl cholera, and coryza (Wang et al., 2012). Sulfadimethoxine inhibits 
the bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid (Vree 
and Hekster, 1987).  
To date, there have been no in vivo studies on the efficacy of sulfadimethoxine in the 
control of C. jejuni in broilers in small-scale poultry operations. Although largely unknown, the 
positive potential effects of sulfadimethoxine antibiotic treatment to control C. jejuni infection in 
chickens should be explored.  
The purpose of this study is to determine the effects of sulfadimethoxine antibiotic on the 
enumeration of Campylobacter spp. and the prevalence on both Campylobacter spp. and           
C. jejuni in growing broilers. Also, this study will examine the effects of sulfadimethoxine 
antibiotic treatments on the enumeration of Campylobacter spp. and prevalence of 
Campylobacter spp. and C. jejuni from the likely sources of cross-contamination including 
water, feed, enclosures and troughs.  
4.2 MATERIALS AND METHODS  
 
4.2.1 Sample Collection 
4.2.1.1 Broiler Production 
Two treatments with two replications each using 300 broiler chickens (Ross × Ross) 
obtained from a commercial hatchery were used. These experiments were conducted from 
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January 2014 to May 2014. Birds were housed in a controlled environment and maintained in 
Petersime
®
Battery Cages (32C) with raised wire flooring. Each cage was divided into 12 pens 
of equal size (29.4” x 39” x 9.5”). Each pen housed twenty-five birds. Feed was procured from 
the Texas Farm Products Company. This feed contains 18% protein chick grower crumbles and 
no antibiotics. Individual water and feed troughs were provided for each pen and feed was 
provided free-choice.  
Birds were allotted to one of two treatments: 1) control (tap water) and 2) drinking water 
+ 0.05% (wt/vol) sulfadimethoxine (Durvet Inc., Blue Springs, Missouri). Drinking water was 
refreshed every day in both treatment groups. The pH value of drinking water was determined 
with a probe electrode portable meter (Beckman 265 pH/ temp/ mV/ Meter). Calibration of the 
pH meter was accomplished using pH 7 and pH 4 standardization buffers. Each week, 150 
individual broilers were randomly sampled using Sterile Rayon Tipped Swabs. The sample 
swabs were placed in a tube containing 3 ml of sterile tryptone soya broth (TSB) for further 
analysis.  
4.2.1.2 Environment Samples 
Two replications, one hundred forty-four samples were randomly collected from drinking 
water, feed and equipment (enclosures and troughs). A 3-5 g feed sample and 5-10 ml drinking 
water sample was collected from each feed and water trough and placed in sterile bottles. Surface 
areas of enclosures and troughs were swabbed and immediately placed into tubes containing 3 ml 
of TSB for further analysis. 
Chicken feces and environment samples were evaluated from January 2014 to May 2014. 
All samples were collected using aseptic techniques in sterile containers and were transported to 
the lab and analyzed at weeks 1, 2, 3, 4, 5 and 6. Quantitative concentration of Campylobacter 
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spp. was determined using the method described by Corry et al. (2003). From the samples, 
Campylobacter spp. was isolated using Latex Agglutination tests (Moore et al., 2005; Miller et 
al., 2008).  
4.2.2 Bacterial Isolation and Identification  
Immediately upon arrival in the laboratory, the swab samples were whirl-mixed in a 
shaker incubator (New Brunswick Scientific Excella™ E24/E24R Temperature-Controlled 
Benchtop Shaker) for approximately 1 h at 37C and then mixed with a vortexer for 2 min to 
release the bacteria. Each 0.1 ml of swab sample was aseptically transferred and directly streaked 
onto modified charcoal cefoperazone deoxycholate agar (mCDDA). The inoculated plates were 
then incubated at 42C for 48 h in a microaerophilic environment (5%O2, 10%CO2, 85%N2). 
Campylobacter spp. was verified by Latex agglutination tests with a Microgen M46 
Campylobacter Assay Kit (Microgen Bioproducts Ltd., Camberley, Surrey, United Kingdom). In 
addition, a hippurate hydrolysis test was performed to confirm C. jejuni (Hwang and Ederer, 
1975).  
4.2.3 Campylobacter Latex Agglutination Kit 
The Microgen Kit is composed of F46a (Test Latex Reagent): latex particles coated with 
rabbit antibodies to Campylobacter antigens, F46b (Control Latex Reagent): latex particles 
coated with non-specific rabbit immunoglobulins, F46c (Positive Control): suspension of 
inactivated Campylobacter antigens reactive with test latex reagent and non-reactive with control 
latex reagent, and F40 (0.85% Isotonic Saline).  
All reagents were allowed to reach room temperature and gently shaken to ensure a 
homogeneous suspension. One drop (50 L) of isotonic saline (F40) was dispensed to each of 
the two ovals of the agglutination slide. An inoculating loop was used to remove several colonies 
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with Campylobacter-like morphology. Bacteria were mixed into each of the two drops of 
isotonic saline (F40) on the slide to form an even suspension. One drop (50 L) of Control Latex 
reagent (F46b) was added to one of the bacterial suspensions on the slide. One drop (50 L) of 
Test Latex Reagent (F46a) was similarly dispensed to the other bacterial suspension. The 
bacterial suspensions were mixed with latex reagents using a mixing stick with the Control Latex 
Reagent (F46b). The mixtures were spread to the edges of the oval areas. The slide was gently 
rocked to keep the fluid suspensions in constant movement for 2 min to produce agglutination. 
Strength of the reaction is variable and was assessed according to the following: + reaction: fine, 
but readily discernible granularity against a milky background, ++ reaction: coarse granularity 
against a milky background, and +++ reaction: heavy clumping of particles around the periphery 
of the test oval, against a clear background. 
4.2.4 Hippurate Hydrolysis Test 
This test is used to determine whether a microorganism, by action of the enzyme 
hippurate hydrolase, can hydrolyze sodium hippurate to benzoic acid and glycine. The glycine 
end product is detected by the addition of ninhydrin reagent and through a complex reaction 
forms a deep purple color that can be easily visualized for the identification of C. jejuni.  
A 1% aqueous solution of sodium hippurate was prepared and dispensed in 0.4 ml 
amounts into 0.2 ml centrifuged tubes. Inoculum from 24 h of Campylobacter growth of the test 
organism was emulsified into a tube of the hippurate solution and incubated in a 37°C for 2 h. 
After incubation, 0.2 ml of the ninhydrin solution was carefully added down the side of the tube 
to form an overlay over the cell mixture so not to mix the solutions. Samples were incubated for 
10 minutes and observed. A deep purple-blue result indicated a positive test for C. jejuni. A 
colorless result indicated a negative result for the presence of C. jejuni. 
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4.2.5 Statistical Analysis 
Statistical procedures were performed using SAS Windows (SAS Institute, 2003).          
A block design with two replications was randomly assigned to the control and experimental 
groups of chicken production.  
All calculations were performed with Proc GLM procedures (SAS, 2003) using   P = 0.05 
for significance of Least Squares Means and simple correlation coefficients among variables 
with a model of the antibiotic sulfadimethoxine administration in chicken production and period 
time testing. Upon the detection of treatment differences, specific comparisons between 
treatment means at that time point were made with the PDIFF option of LSMEANS. 
4.3 RESULTS AND DISCUSSION  
4.3.1 Environment Samples 
4.3.1.1 Drinking Water 
The optimum pH growth environment for Campylobacter spp. is 6.5–7.5. However, 
cultures can survive at pH levels between 4.9 and 9.0. At pH levels below 4.0, cells rapidly die, 
especially under refrigeration temperatures (ICMSF, 1996). In this study, the initial pH value of 
the non-treated drinking water (control treatment) was 7.97 and the drinking water + 0.05% 
sulfadimethoxine (antibiotic treatment) was at pH 8.30. 
Over the six week period, Campylobacter spp. counts from the control treatment ranged 
from 0-2.56 log CFU/ml. In the antibiotic treatment, the results ranged from 0-2.10 log CFU/ml 




Figure 4.1 Campylobacter spp. bacterial counts in drinking water samples from the control and 
antibiotic treatments from weeks 1 through 6. Data are means from two experiments. 
a,b
Treatment means with different superscripts for the same week are significantly different, 
P<0.05. SEM = 1.1451. 
 
The presence of Campylobacter spp. was not detected in drinking water samples in weeks 
1 or 2. However, the presence of Campylobacter spp. was detected in week 3 and continued to 
increase during the course of the experiment in both the control and antibiotic treatments. 
However, the levels of Campylobacter spp. were slightly higher (P>0.05) in the control treatment 
when compared to the antibiotic treatment (Figure 4.1).  
In the antibiotic treatment, Campylobacter spp. increased by 0.88 log CFU/ml whereas, 
in the control treatment, it increased by 1.24 log CFU/ml from weeks 3 to 6. Subsequently, these 
results clearly show that the enumeration of Campylobacter spp. in water samples was 
significantly higher (P<0.05) in the control treatment than in the antibiotic treatment at week 6 
(Figure 4.1). These results suggest that the application of a 0.05% concentration of 
sulfadimethoxine can reduce the presence of Campylobacter spp. in the drinking water, thereby 
mitigating cross-contamination.  
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The prevalence of Campylobacter spp., verified by latex agglutination tests, ranged from 
0% to 50% (72|144 samples) in the control treatment and ranged from 0% to 41.67% (60|144 
samples) in the antibiotic treatment over the six-week period (Table 4.1).  
Table 4.1 The prevalence of Campylobacter spp. and C. jejuni in drinking water samples from 
the control and antibiotic treatments from weeks 1 through 6.  
 
Week 
No. (%) of positive samples of 
Campylobacter spp. (n = 144) 
No. (%) of positive samples of 





























































ND = Non detectable. Data are means from two experiments. 
a,b
Treatment means with different 
superscripts for the same week are significantly different, P<0.05.  SEM for Campylobacter spp. 
= 0.0189; SEM for C. jejuni = 0.0194. 
 
The presence of Campylobacter spp. was not detected in either the control or antibiotic 
water samples in weeks 1 or 2. This suggests that little or no Campylobacter spp. cross-
contamination had occurred. However, the presence of Campylobacter spp. in the drinking water 
was initially detected in both the control and antibiotic treatments in week 3.  In week 3, the 
prevalence of Campylobacter spp. was measured at 33.33% (48|144 samples) in both the control 
and antibiotic treatments (Table 4.1).  
In week 4, the prevalence of Campylobacter spp. declined in both the control and 
antibiotic treatments. Specifically, the prevalence was measured at 16.67% (24|144 samples) in 
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the antibiotic treatment and at 25% (36|144 samples) in the control treatment (Table 4.1). At 
week 5, the prevalence of Campylobacter spp. increased to 41.67%, (60|144 samples) in the 
control treatment and to 25% (36|144 samples) in the antibiotic treatment. At week 6, the control 
treatment exhibited a significantly higher prevalence of Campylobacter spp. (P<0.05) at 50% 
(72|144 samples) than in the antibiotic treatment at 41.67% (60|144 samples) (Table 4.1). These 
results demonstrate that the prevalence of Campylobacter spp. was significantly less in the 
treated drinking water than in the control. 
 The prevalence of C. jejuni as determined through hippurate hydrolysis in drinking water 
samples ranged from 0% (0|144 samples) to 41.67% (60|144 samples) in the control treatment 
and from 0% (0|144 samples) to 27.78% (40|144 samples) in the antibiotic treatment over the 
six-week period of testing (Table 4.1). At weeks 1 and 2, C. jejuni was not detected. At week 3, 
the prevalence of C. jejuni was measured at 16.67% (24|144 samples) in the control treatment 
and 8.33% (12|144 samples) in the antibiotic treatment (Table 4.1).  
The prevalence of C. jejuni was measured at 8.33% (12|144 samples) in both the control 
and antibiotic treatments at week 4 (Table 4.1). At week 5, the prevalence of C. jejuni increased 
to 25.0%, (36|144 samples) in the control treatment but it was stable at 8.33% in the antibiotic 
treatment (Table 4.1). At week 6, the control treatment exhibited a significantly higher 
prevalence of C. jejuni (P<0.05) at 41.67% (60|144 samples) than in the antibiotic treatment at 
27.78% (40|144 samples) (Table 4.1). These results indicated that the prevalence of C. jejuni in 
the antibiotic treatment decreased by 28.80% (20|144 samples) as compared to the control in 
week 6 (Table 4.1). These results suggest that the administration of 0.05% sulfadimethoxine 
reduces the prevalence of C. jejuni in drinking water. In a small-scale poultry setting, this 




In this study, fresh feed from each bag was tested for Campylobacter spp. and C. jejuni 
before it was fed to the broilers. Neither Campylobacter spp. nor C. jejuni was detected. 
Subsequently, Campylobacter spp. counts from feed samples ranged from 0-1.80 log CFU/ml in 
the control treatment and from 0-1.30 log CFU/ml in the antibiotic treatment over the six-week 
test period (Figure 4.2). Campylobacter spp. was not detected in either the control or antibiotic 
treatments in weeks 1, 2, 4, and 5. However, the presence of Campylobacter spp. was detected in 
both the antibiotic and control treatments in week 3. Specifically, Campylobacter spp. was 
detected at a concentration of 1.80 log CFU/ml in the control treatment and at 0.82 log CFU/ml 
in the antibiotic treatment. These calculations suggest a significant difference (P<0.05) between 
the control and antibiotic treatments. However, at week 6 the difference was not significant 
(P>0.05) as the concentration of Campylobacter spp. in the control was determined to be 0.22 
log CFU/ml and 0.00 log CFU/ml in the antibiotic treatment (Figure 4.2). The reason for the 
Campylobacter spp. spike in week 3 is uncertain. This spike might be the result of a simple 
anomaly or it might represent a one-time event.  
The prevalence of Campylobacter spp. in the feed samples ranged from 0% to 50.0% 
(72|144 samples) in the control treatment and from 0-16.67% (24|144 samples) in the antibiotic 
treatment (Table 4.2). As was the case in the enumeration study, Campylobacter spp. was not 
detected in weeks 1, 2, 4, and 5 in either the control or antibiotic treatments. The prevalence of 




Figure 4.2 Campylobacter spp. bacterial counts in feed samples from the control and antibiotic 
treatments from weeks 1 through 6. Data are means from two experiments. 
a,b
Treatment means 
with different superscripts for the same week are significantly different, P<0.05. SEM = 0.4294. 
 
Table 4.2 The prevalence of Campylobacter spp. and C. jejuni in feed samples from the control 
and antibiotic treatments from weeks 1 through 6.  
 
Week 
No. (%) of positive samples of 
Campylobacter spp. (n = 144) 
No. (%) of positive samples of 





























































ND = Non detectable. Data are means from two experiments. 
a,b
Treatment means with different 
superscripts for the same week are significantly different, P<0.05.  SEM for Campylobacter spp. 
= 0.0191; SEM for C. jejuni = 0.0128. 
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Specifically, in the control treatment, prevalence was determined at 50% (72|144 samples) and at 
16.67% (24|144 samples) in the antibiotic treatment (Table 4.2).  
At week 6, the prevalence of Campylobacter spp. at 8.33% (12|144 samples) in the 
control treatment was significantly different (P<0.05) than that of the antibiotic treatment at 
0.00% (0|144 samples). As was the case in the enumeration test, the prevalence test shows fewer 
spikes. For the reasons stated above, an explanation of this spike is uncertain. 
As was the case in the previous tests, the prevalence of the specific bacterium, C. jejuni 
spiked in week 3 in both treatments. However, the prevalence of 25% (36|144 samples) in the 
control was significantly higher (P<0.05) than in the antibiotic treatment 8.33% (12|144 samples) 
(Table 4.2). C. jejuni was not detected in weeks 1, 2, 4, 5, and 6 (Table 4.2). Although the spike 
in week 3 is consistent with the previous tests, the reason for this remains uncertain. Therefore, 
the use of the antibiotic might still be useful in controlling these kinds of spikes that could lead to 
a significant cross-contamination event.  
4.3.1.3 Enclosures and Troughs 
In this study, enclosures and troughs were sampled for enumeration of Campylobacter 
spp. and for the prevalence of Campylobacter spp. and C. jejuni. Of the 144 samples taken from 
each of the control and experimental groups during the six-week period of testing, none were 
positive for Campylobacter spp. or C. jejuni.  
As stated previously, enclosures and troughs were tested because they might harbor 
Campylobacter spp. and, therefore, contribute to cross-contamination during poultry production. 
Because the control samples showed no incidence of Campylobacter spp. it appears that 
enclosures and troughs are not a significant point of bacterial refuge. Therefore, enclosures and 
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troughs do not appear to be a material concern in controlling Campylobacter spp. in small-scale 
poultry production.   
4.3.2 Live Broilers 
4.3.2.1 Enumeration Testing 
 Enumeration test were performed at the McNeese State University Agricultural Sciences 
laboratory for two replications on 300 chickens from January through May 2014. For each 
replication, 150 individual chickens were used. The control and antibiotic treatments each 
consisted of 75 birds.   
From these enumeration tests, counts of Campylobacter spp. steadily increased from 
week 1 through week 6 in both the control and antibiotic treatments (Figure 4.3). The counts of 
Campylobacter spp. in the control treatment increased from an initial value of 3.58 log CFU/ml 
in week one to a maximum value of 6.05 log CFU/ml in week six. This represents a total 
increase of 2.47 log CFU/ml during the course of the experiment. In the antibiotic treatment the 
initial value of 3.44 log CFU/ml in week one increased to a maximum value of 5.12 log CFU/ml 
in week six (Figure 4.3). This represents a total increase of 1.68 log CFU/ml. 
There was no significant difference in the enumeration of Campylobacter spp. in the 
antibiotic treatment (P>0.05) and the control treatment in weeks 1 through 5. However, the 
enumeration of Campylobacter spp. was significantly higher in the control treatment than the 
antibiotic treatment (P<0.05) at week 6 (Figure 4.3).  
For the overall experiment, the enumeration of Campylobacter spp. in the antibiotic 
treatment was lower than in the control treatment (Figure 4.3). These results suggest that the 
antibiotic sulfadimethoxine, as applied in this experiment can reduce the enumeration of 




Figure 4.3 Enumeration results on Campylobacter spp. in live broilers from the control and 
antibiotic treatments from weeks 1 through 6. Data are means from two experiments. 
a,b
Treatment means with different superscripts for the same week are significantly different, 
P<0.05. SEM = 4.9738. 
 
4.3.2.2 Prevalence Testing 
4.3.2.2.1 Campylobacter spp. 
Prevalence tests for Campylobacter spp. were performed for two replications on 300 
chickens from January through May 2014. For each replication, 150 individual chickens were 
used. The control and experimental treatments each consisted of 75 birds.   
For each of the test weeks, the prevalence of Campylobacter spp. in individual broilers 
from the control treatment ranged from 37.33% (56|150 samples) to 66.67% (100|150 samples). 
From the antibiotic treatment, the prevalence ranged from 13.33% (20|150 samples) to 65.33% 
(98|150 samples) (Table 4.3). At week 1, the prevalence of Campylobacter spp. was significantly 
lower in the antibiotic treatment (P<0.05) than in the control treatment (Table 4.3). In weeks 2 
and 3, the prevalence of Campylobacter spp. declined by 51.00% (34|150 samples) in the 
antibiotic treatment but increased by 36.00% (24|150 samples) in the control treatment.  
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Table 4.3 The prevalence of Campylobacter spp. and C. jejuni in live broilers from the control 
and antibiotic treatments from weeks 1 through 6.  
 
Week 
No. (%) of positive samples of 
Campylobacter spp. (n = 150) 
No. (%) of positive samples of 





























































Data are means from two experiments. 
a,b
Treatment means with different superscripts for the 
same week are significantly different, P<0.05.  SEM for Campylobacter spp. = 0.0344; SEM for 
C. jejuni = 0.0366. 
 
In week 3, the prevalence of Campylobacter spp. was significantly higher in the control 
treatment than the antibiotic treatment (P<0.05) (Table 4.3). Specifically, there was a 13.33% 
(20|150) incidence in the antibiotic treatment and a 53.33% (80|150) incidence in the control 
treatment. These finding showed that the antibiotic sulfadimethoxine can reduce the prevalence 
of Campylobacter spp. in broilers especially in this week (Table 4.3).  
In week 4, the prevalence of Campylobacter spp. increased to 52.0%, (78|150 samples) in 
the antibiotic treatment but it was unchanged at 53.33% (80|150 samples) in the control 
treatment. In week 5, the prevalence of Campylobacter spp. declined somewhat in both 
treatments. Specifically, the prevalence was measured at 41.33% (62|150 samples) in the 
antibiotic treatment and at 42.67% (64|150 samples) in the control treatment (Table 4.3).            
In week 6, the prevalence of Campylobacter spp. in the control treatment was measured at 
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66.67% (100|150 samples) and in the antibiotic treatment was measured at 65.33% (98|150 
samples) (Table 4.3). Overall, for the six-week period of testing, the prevalence of 
Campylobacter spp. in the antibiotic treatment was lower (P<0.05) than in the control treatment 
(Table 4.3).  
4.3.2.2.2 C. jejuni 
Prevalence tests for C. jejuni were performed for two replications on 300 chickens from 
January through May 2014. For each replication, 150 individual chickens were used. The control 
and antibiotic treatments each consisted of 75 birds.   
In this study, the overall prevalence of C. jejuni in the control treatment ranged from 
33.33% (50|150 samples) to 56.00% (84|150 samples) and from 13.33% (20|150 samples) to 
50.00% (75|150 samples) in the antibiotic treatment (Table 4.3).  
In week 1, the prevalence of C. jejuni was significantly higher (P<0.05) in the control 
treatment at 41.33% (62|150 samples) than in the antibiotic treatment at 25.33% (38|150 
samples) (Table 4.3). In week 2, the prevalence of C. jejuni was the same in both control and 
antibiotic treatments at 33.33% (50|150 samples) (Table 4.3). In week 3, the prevalence of        
C. jejuni declined in the antibiotic treatment to 13.33% (20|150 samples) whereas, it increased to 
45.33% (68|150 samples) in the control treatment. These values represent a significant difference 
(P<0.05) (Table 4.3).   
In week 4, the prevalence of C. jejuni was at 45.33% (68|150 samples) in the antibiotic 
treatment and at 48.00% (72|150 samples) in the control treatment (Table 4.3). These values are 
not significantly different (P>0.05) (Table 4.3). In week 5, the prevalence of C. jejuni was at 
41.33% (62|150 samples) in the antibiotic treatment and at 42.67% (64|150 samples) in the 
control treatment (Table 4.3). These values are not significantly different (P>0.05) (Table 4.3). In 
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week 6, the prevalence of C. jejuni was significantly higher (P<0.05) in the control treatment at 
56.00% (84|150 samples) than in the antibiotic treatment at 50.00% (75|144 samples) (Table 
4.3). For the overall experiment, the prevalence of C. jejuni in the antibiotic treatment was 
significantly lower (P<0.05) than in the control treatment (Table 4.3). These results suggest that 
the antibiotic sulfadimethoxine, as applied in this experiment can reduce the prevalence of         
C. jejuni in the broilers. 
4.3.3 Summary  
This study indicates the use of antibiotic sulfadimethoxine can reduce the enumeration of 
Campylobacter spp. and the prevalence of Campylobacter spp. and C. jejuni in small-scale 
poultry farming. This is the first study in which sulfadimethoxine has been used in an in vivo 
setting to control Campylobacter. Therefore, this study supplies the first such data in the 
literature. 
Results from other studies whose aim was to control C. jejuni in poultry are mixed. For 
example, the study by Robyn et al. (2013) attempted to inhibit C. jejuni in chickens through the 
administration of live bacterium Enterococcus faecalis. As they reported, this bacterium failed to 
inhibit the growth of C. jejuni. In a second study, Caravalho et al. (2010) found that 
bacteriophage lytic cocktail administered to chickens resulted in a 2 log CFU/ml reduction in the 
enumeration of C. jejuni.  In a third study using turkeys, the administration of the antibiotics 
enrofloxacin, neomycin and vancomycin resulted in a respective decrease of 1, 2 and 4 log 
CFU/ml of C. jejuni (Scupham et al., 2010). For purposes of comparison, the present study found 
that the use of sulfadimethoxine resulted in a decrease of 0.93 log CFU/ml in the experimental 
group as compared to the control group. Therefore, the positive results from this study compare 
favorably with the previously mentioned second and third studies.  
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 The quantitative risk assessment model of Messens et al. (2007) suggests that reducing 
Campylobacter spp. levels by 1, 2 and 3 log CFU/ml could result in a reduction in the prevalence 
of Campylobacter spp. by 55%, 81% and 94% respectively. However, this model is not 
supported by the present study. Specifically, the enumeration of Campylobacter spp. in the 
experimental group decreased by 0.93 log CFU/ml as compared to the control group but the 
prevalence of Campylobacter spp. was only reduced by 1.34%. Therefore, this issue remains 
unresolved. Additional future studies may help bring a resolution here.  
Finally, as a practical matter results from this study suggest that the administration of 
antibiotics via drinking water should be closely monitored. Specifically, results show that 
drinking water may be a prime source of bacterial cross contamination. Therefore, sound 
sanitation practices are critical in the control of Campylobacter contamination. To this end, water 
troughs should be regularly cleaned and disinfected with Nolvasan Solution.  
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This dissertation research addresses several problems concerning the prevalence, 
enumeration, and control of Campylobacter spp. and C. jejuni in a small-scale poultry production 
setting. For the most part the results have successfully addressed these problems with new 
findings and insight. The most important conclusion from this research is that although the 
antibiotic sulfadimethoxine was shown to reduce the prevalence of C. jejuni, its application as an 
effective bacterial control is not supported.   
This research also indicates that abiotic factors have the potential to contribute to 
horizontal cross contamination of C. jejuni. Most notably, water and feed represent likely sources 
for cross contamination.  Therefore, sound sanitation practices are of paramount concern in small 
scale poultry farming. Although other sources have suggested that egg shells might provide a 
vertical means of cross contamination, this research found this not to be the case.  
Because this research represents an initial inquiry in the control of C. jejuni in small scale 
poultry production, other question remain. It is contemplated that future research will provide 
additional evidence related to this issue. For example, future studies might explore 
sulfadimethoxine drug residue in chicken meat. This is a concern because antibiotic drug residue 
carryover may adversely affect the health of the consumer. Because C. jejuni is a bacterium, it 
has the potential to become resistant to antibiotics. Therefore, future study may address this issue 
with respect to the long-term use of sulfadimethoxine in poultry production.  Additionally, future 
studies might explore the use of sulfadimethoxine to control other pathogenic bacteria that infect 
poultry. Among others these may include E. coli O157:H7 and Salmonella typhimurium.  
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In the present study, the presence of C. jejuni was detected via feces. However, other 
studies might contribute additional information by testing other matrices. As commonly 
practiced, these may include caeca, crop, and the intestinal tract.  In the present study, 
biochemistry methods were employed. However, real-time PCR methods could be used to 
enhance the detection, isolation, and quantification of C. jejuni. PCR methods provide precise 
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